Title:
【発明の名称】CETP阻害剤としての4-アミノ置換-2-置換-1,2,3,4-テトラヒドロキノリン
Document Type and Number:
Japanese Patent JP2002526476
Kind Code:
A
Abstract:
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Inventors:
Deninno, Michael Paul
Magnus-Arytay, George Tette
Ruggeri, Roger Benjamin
Ronald Saa, Wester
Magnus-Arytay, George Tette
Ruggeri, Roger Benjamin
Ronald Saa, Wester
Application Number:
JP2000574075A
Publication Date:
August 20, 2002
Filing Date:
September 10, 1999
Export Citation:
Assignee:
Pfizer Products Inc.
International Classes:
A61K31/47; A61K31/4706; A61K31/4709; A61K31/473; A61K45/00; A61P3/04; A61P3/06; A61P9/00; A61P9/10; A61P9/12; C07D215/16; A61P31/00; C07D215/00; C07D215/42; C07D215/46; C07D221/06; C07D221/16; C07D413/12; C07D417/12; A61K; C07D; (IPC1-7): C07D215/16; A61K31/4706; A61K31/473; A61K45/00; A61P3/04; A61P3/06; A61P9/00; A61P9/10; A61P9/12; A61P31/00; C07D221/06
Attorney, Agent or Firm:
Kazuo Shamoto (5 outside)
Previous Patent: ＣＥＴＰ阻害剤としての４−カルボキシアミノ−２−置換−１，２，３，...
Next Patent: ＣＥＴＰ阻害剤としての４−カルボキシアミノ−２−メチル−１，２，３...
Next Patent: ＣＥＴＰ阻害剤としての４−カルボキシアミノ−２−メチル−１，２，３...